Year: 2025
Type: article
Abstract: Alzheimer’s disease remains one of the most pressing neurodegenerative disorders, with limited treatment options, making the identification of novel therapeutic targets a crucial research challenge. In this study, we focused on the HtrA serine peptidase 1 (HTRA1) recep
Source: European Science Review
Author: William Lin
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4410919834